Athyrium Opportunities Iv Acquisition 2 Lp - Net Worth and Insider Trading
Athyrium Opportunities Iv Acquisition 2 Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Athyrium Opportunities Iv Acquisition 2 Lp owns 1 companies in total, including RVL Pharmaceuticals PLC (RVLPQ) .
Insider Ownership Summary of Athyrium Opportunities Iv Acquisition 2 Lp
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RVLPQ | RVL Pharmaceuticals PLC | 2022-08-08 | 10 percent owner |
Athyrium Opportunities Iv Acquisition 2 Lp Trading Performance
Athyrium Opportunities Iv Acquisition 2 Lp Ownership Network
Athyrium Opportunities Iv Acquisition 2 Lp Owned Company Details
What does RVL Pharmaceuticals PLC do?
Who are the key executives at RVL Pharmaceuticals PLC?
Athyrium Opportunities Iv Acquisition 2 Lp is the 10 percent owner of RVL Pharmaceuticals PLC. Other key executives at RVL Pharmaceuticals PLC include 10 percent owner Foundation Harsaul , 10 percent owner Altchem Ltd , and director & 10 percent owner David F Burgstahler .
RVL Pharmaceuticals PLC (RVLPQ) Insider Trades Summary
Over the past 18 months, Athyrium Opportunities Iv Acquisition 2 Lp made no insider transaction in RVL Pharmaceuticals PLC (RVLPQ). Other recent insider transactions involving RVL Pharmaceuticals PLC (RVLPQ) include a net sale of 17,544,196 shares made by Foundation Harsaul , and a net sale of 17,544,196 shares made by Altchem Ltd .
In summary, during the past 3 months, insiders sold 0 shares of RVL Pharmaceuticals PLC (RVLPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 35,088,392 shares of RVL Pharmaceuticals PLC (RVLPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 35,088,392 shares.
RVL Pharmaceuticals PLC (RVLPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
RVL Pharmaceuticals PLC Insider Transactions
Athyrium Opportunities Iv Acquisition 2 Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Athyrium Opportunities Iv Acquisition 2 Lp. You might contact Athyrium Opportunities Iv Acquisition 2 Lp via mailing address: 505 Fifth Avenue, Floor 18, New York Ny 10017.